Annovera - A New Contraceptive Vaginal Ring

Date: December 16, 2019 Issue #:  1587Summary: Annovera (TherapeuticsMD), a contraceptive vaginal ring that releases segesterone acetate, a synthetic progestin, and ethinyl estradiol, was approved by the FDA in 2018 and is now available. It is the first product to contain segesterone and the second vaginal ring to become available in the US;NuvaRing, which delivers etonogestrel and ethinyl estradiol, was the first. UnlikeNuvaRing, which requires use of a new ring each month, theAnnovera ring can be used for an entire year, but it must be removed for one week each month.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: Tags: Annovera Contraceptives Estrogens etonogestrel IUD Nexplanon NuvaRing ombitasvir paritaprevir Progestins Ritonavir segesterone Technivie Viekira Pak Source Type: research